AstraZeneca said on Tuesday it would sell rights to its cholesterol drug, Crestor, to German pharmaceutical company Grünenthal GmbH for an upfront payment of $320 million.from Top Business News- News18.com https://ift.tt/2Vjp9Zt
via IFTTT
Tuesday, 1 December 2020
AstraZeneca Sells Cholesterol Drug Rights To Grünenthal For $320 Million
AstraZeneca said on Tuesday it would sell rights to its cholesterol drug, Crestor, to German pharmaceutical company Grünenthal GmbH for an upfront payment of $320 million.from Top Business News- News18.com https://ift.tt/2Vjp9Zt
via IFTTT
Subscribe to:
Post Comments (Atom)
-
Krsnaa Diagnostics IPO Allotment: Investors can check the share allotment status in two ways a) via BSE b) via registrar’s website from To...
-
Theyve endured a financial crisis. Two deep recessions. Mounds of student debt. Stagnant pay. Costly health care. Dim job prospects. from ...
-
ArcelorMittal SA, the world's largest steelmaker, is exploring a deal to merge its U.S. operations with ClevelandCliffs Inc, the largest...
No comments:
Post a Comment